In vitro effect of 5-fluorouracil and paclitaxel on Echinococcus granulosus larvae and cells

(1)

HAL Id: hal-03179490

https://hal.univ-angers.fr/hal-03179490

Submitted on 24 Mar 2021

HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.

L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

In vitro effect of 5-fluorouracil and paclitaxel on Echinococcus granulosus larvae and cells

Patricia Pensel, C Albani, Gabriela Veroniva Ullio Gamboa, Jean-Pierre Benoit, María Elissondo

To cite this version:

Patricia Pensel, C Albani, Gabriela Veroniva Ullio Gamboa, Jean-Pierre Benoit, María Elissondo. In

vitro effect of 5-fluorouracil and paclitaxel on Echinococcus granulosus larvae and cells. Acta Tropica,

Elsevier, 2014, 140, pp.1-9. �10.1016/j.actatropica.2014.07.013�. �hal-03179490�

(2)

ContentslistsavailableatScienceDirect

Acta Tropica

j ou rn a l h o m epa g e :w w w . e l s e v i e r . c o m / l o c a t e / a c t a t r o p i c a

In vitro effect of 5-ﬂuorouracil and paclitaxel on Echinococcus granulosus larvae and cells

P.E. Pensel

^a,c

, C. Albani

^a,c

, G. Ullio Gamboa

^b,c

, J.P. Benoit

^d

, M.C. Elissondo

^a,c,∗

aLaboratoriodeZoonosisParasitarias,Fac.CienciasExactasyNaturales,UniversidadNacionaldeMardelPlata,CONICET,MardelPlata,Argentina

bLaboratoriodeFarmacotecnia,Fac.CienciasQuímicas,UniversidadNacionaldeCórdoba,UNITEFA,Córdoba,Argentina

cConsejoNacionaldeInvestigacionesCientíﬁcasyTécnicas(CONICET),BuenosAires,Argentina

dINSERMU1066,MINT—MicroetNanomédecinesBiomimétiques,IBS-CHUAngers,49933AngersCedex9,France

a r t i c l e i n f o

Articlehistory:

Received26March2014

Receivedinrevisedform27June2014 Accepted23July2014

Availableonline1August2014

Keywords:

Cystechinococcosis Echinococcusgranulosus Hydatidcysts 5-Fluorouracilo Paclitaxel

a b s t r a c t

HumancysticechinococcosisisazoonosiscausedbythemetacestodestageofthetapewormEchinococcus granulosus.Althoughbenzimidazolecompoundssuchasalbendazoleandmebendazolehavebeenthe cornerstoneofchemotherapyforthedisease,thereisoftennocompleterecoveryaftertreatment.Hence, insearchingfornoveltreatmentoptions,weexaminedtheinvitroefﬁcaciesof5-ﬂuorouracil(5-FU)and paclitaxel(PTX)againstE.granulosusgerminalcells,protoscolecesandcysts.5-FUorPTXinhibitedthe growthofE.granulosuscellsinatimedependentmanner.Althoughbothtreatmentshadaprotoscolicidal effect,5-FUhadaconsiderablystrongereffectthanPTX.5-FUproducedadose-andtime-dependent effect,provokingthecompletelossofviabilityafter24daysofincubation.Moreover,cystsdidnotdevelop followingtheinoculationoftreatedprotoscolecesintomice.ThelossofviabilitywasslowerinPTXtreated protoscoleces,reachingtoapproximately60%after30days.Theresultsoftheinvitrotreatmentwith5- FUandPTXweresimilarinsecondarymurinecysts.TheemploymentofSEMandTEMallowedusto examine,atanultrastructurallevel,theeffectsinducedby5-FUandPTXonE.granulosusgerminalcells, protoscolecesandmurinecysts.Inconclusion,thedataobtainedclearlydemonstratedthat5-FUandPTX atclinicallyachievableconcentrationsinhibitthesurvivaloflarvalcells,protoscolecesandmetacestodes.

Invivostudiestotesttheantiparasiticactivitiesof5-FUandPTXarecurrentlybeingundertakenonthe murinemodelofcysticechinococcosis.

1. Introduction

Cystic echinococcosis (CE)caused by the larval stageof the tapewormEchinococcusgranulosusisachronic,complex,andstill neglectedparasiticinfectiondisease(Brunettietal.,2011).Human orungulateintermediatehosts(sheep,goats,pigs,cattle,horses orcamels)becomeinfectedafteringestionofeggspassedintothe environmentwithfaecesfromdeﬁnitivehosts(dogsandwolves).

Theoutcomeofinfectionisthedevelopmentofﬂuid-ﬁlledcysts mainlyintheliverandthelungs,althoughotherorganscanalsobe affected(Budkeetal.,2013).

The WHO-IWGE classiﬁcation providesthe basis for choos- ing basically four treatment and management options for CE: surgery, percutaneous sterilization, chemotherapy with

∗Correspondingauthorat:LaboratoriodeZoonosisParasitarias,FacultaddeCien- ciasExactasyNaturales,UniversidadNacionaldeMardelPlata(UNMdP),Funes 3250,7600MardelPlata,Argentina.Tel.:+542234752426;fax:+542234753150.

E-mailaddresses:c.elissondo@gmail.com,mceliss@mdp.edu.ar(M.C.Elissondo).

benzimidazolesandobservation(watchandwait)forinactive,clin- icallysilentcysts(Brunettietal.,2011).Eachofthesetherapeutic toolshaslimitationsdependingontheindividualcase.Theevi- dencesupportinganyofthesemodalitiesfromcarefullydesigned clinicalstudiesisinsufﬁcientandthechoiceoftreatmentoptions remainscontroversial(Stojkovicetal.,2009).

Medical treatmentis indicatedwhen surgicalremoval isnot appropriateforpatientswithmultiplecystsintwoormoreorgans, forpreventionof secondaryechinococcosisaftersurgery andin somecasesforpresurgicaltreatment(Pawlowskietal.,2001).The benzimidazole(BZ)compounds–albendazole(ABZ)andmeben- dazole(MBZ)–havebeenthecornerstoneofchemotherapyforCE (McManusetal.,2012).

Severalfactorsaffecttheresponsetomedicaltreatment,suchas sizeandageofthecysts,thicknessofhostderivedconnectivetis- sue,calciﬁcation,cystcomplicationwithmultiplecompartments ordaughtercysts,abilityofthedrugtopenetratethecystwalland persistenceofadequatelevelof drugoritsactivemetaboliteat thesiteofparasitelocation(Ceballosetal.,2008;Hemphilland Müller,2009).ApproximatelyathirdofpatientstreatedwithBZ http://dx.doi.org/10.1016/j.actatropica.2014.07.013

(3)

2 P.E.Penseletal./ActaTropica140(2014)1–9

drugshavebeencured,30–50%developsomeevidenceofathera- peuticresponsewhilebetween20and40%ofcasesdonotrespond favorably(MoroandSchantz,2009).Moreover,BZsometimesacts exclusivelyasaparasitostaticagent,andrelapsesafterchemother- apyhavebeenreported(Stamatakosetal.,2009).

Praziquantel(PZQ),aheterocyclicpyrazinoisoquinolinederiva- tive,hasbeenproposedtobeusedalongsideBZinCE-patients.

Nevertheless,furtherstudiesarerequiredtodeterminewhether there are significantbenefitsfrom a combination therapy with ABZandPZQovermonotherapywithABZ(Bygott andChiodini, 2009).Withregardtothesedifficulties,thedevelopmentofanew therapeuticdrugforhumantreatmentofcysticechinococcosisis necessary.

There are a number of similarities between cancer cells and some parasites (Klinkert and Heussler, 2006). Particu- larly,Echinococcusmetacestodesexhibittumor-likeproperties,as reﬂectedbytheirseeminglyunlimited growthand proliferation potential,andtheirabilitiestomodulatetheimmuneresponseand toformmetastases(Hemphilletal.,2007).Consequently,several drugsinhibitingproliferationofcancercellshavebeenassayedon Echinococcusmetacestodesandprotoscoleces(HemerandBrehm, 2012;Hübneretal.,2010;Küsteretal.,2012;Lianceetal.,1993;

Naguleswaranetal.,2006;Spicheretal.,2008a,b).Doxorubicin, adrugcommonlyusedinthetreatmentofawiderangeofcan- cers,showedinvivoparasiticidalpropertiesagainstE.multilocularis afterbindingtopolyisohexylcyanoacrylatenanoparticles(Liance etal.,1993).Theinvitroandinvivoeffectsof2-methoxyestradiol, artemisininandartemisininderivativesagainstE.granulosusandE.

multilocularislarvalstageswereevaluated(Spicheretal.,2008a,b).

Furthermore,theisoﬂavonegenisteinandthegenisteinderivative Rm6423exhibited profoundinvitro activitiesagainstthemen- tionedparasites(Naguleswaranetal.,2006).

Fluoropyrimidineweredevelopedinthe1950sfollowingthe observationthatrathepatomasusedexogenousuracilmorerapidly than normal tissues, indicating that uracil metabolism was a potentialtargetforantimetabolitechemotherapy(Rutmanetal., 1954).Heidelbergerandcolleaguessynthesized5-ﬂuorouracil(5- FU), which differs from uracil by virtue of a ﬂourine atom in placeofhydrogenatthecarbon-5positionofthepyrimidinering (Heidelbergeretal.,1957).Thisdrugiswidelyusedinthetreat- mentofarangeofcancersincludingbreastcancerandcancersof theaerodigestivetract,buthashadthegreatestimpactincolorectal tumors(Longleyetal.,2003).5-FUhasinvitroandinvivoantiprolif- erativeeffectonendometrioticcells(Ngôetal.,2010).Furthermore, anti-malarialactivityof5-FUagainstPlasmodiumfalciparumhas beendemonstrated(Rathodetal.,1989).

Anotheranticanceragentisaditerpeneplantproductderived fromthewesternyew Taxus brevifolia,namelypaclitaxel(PTX) (Wanietal.,1971).PTXhasantineoplasticpropertiesandisused totreatcertainhumanmalignancies(RowinskyandDonerhower, 1995;Huizingetal.,1995).InvitrostudieshaveshownthatPTX inhibitsthegrowthoftheapicomplexanparasitesP.falciparumand Toxoplasmagondii(Pouvelleetal.,1994;Estesetal.,1998).

Theaimofthepresentworkwastodeterminetheinvitroeffect of5-FUandPTXagainstE.granulosusgerminalcells,protoscoleces andcyst.

2. Materialsandmethods

2.1. Drugtreatments

Paclitaxel(Indena,Milan,Italy)and5-FU(RocheLaboratories, Neuilly-sur-Seine, France) were dissolvedin dimethyl sulphox- ide(DMSO) atadrugconcentrationof10mg/ml.5-FUand PTX were added to the medium 199 (Gibco BRL) resulting in ﬁnal

concentrationsof10,5and1␮g/ml(5-FU:75,37.5,7.5␮M;PTX:12, 6,1.2␮M).Theﬁnalvolumeofdrugsolutionaddedtothemedium was0.1%.Controlculturecontained0.1%DMSO.

2.2. Parasitematerialandcellculture

Hydatidcystsfromliverandlungsofnaturallyinfectedcattle wereobtainedfromaslaughterhouselocatedinthesoutheastof theBuenosAiresprovince,Argentina.E.granulosuscellculturewas obtainedusingpreviouslyreportedmethods(Albanietal.,2010).

Inbrief,cellswereculturedat37^◦Cinmedium199supplemented with 10% FBS, 10% hydatid ﬂuid, reducing agents (5×10⁻⁵M 2-mercaptoethanol and 100␮M l-cysteine), 2mM l-glutamine (Bio-Rad,USA),40␮g/mlglucose(Sigma,USA),1mMsodiumpyru- vate (Sigma, USA) and antibiotics (penicillin, streptomycin and gentamicin100␮g/ml).E.granulosuscells werecultivatedforat least4weeks.Theculturemediumwaschangedweeklyandcells weresubculturedonceaweekatasplitratio1:2(Albanietal., 2010).

2.3. Growthinhibitoryassayonisolatedcells

E.granulosuscellswereseededin24-wellmicroplates(5×10⁵ cells/wellin1mlmedium).Forthisexperimentcellculturesafter 24hofsubculturewereused.5-FUandPTXwereaddedinserial concentrations(10,5and1␮g/ml)andcultureswereincubatedfor 7days.Atdays0,2,5and7viabilitywasassessedbytrypanblue dye(Sigma,USA)exclusionusingahemocytometer.Cultureswere followedmicroscopicallytodeterminetheappearanceofmorpho- logicalalterations.Atdays2,5and7oftreatment,sampleswere takenforscanningelectronmicroscopy(SEM).

2.4. Protoscolecescollectionandinvitroincubationprocedures Protoscoleceswereremovedfromcystsunderasepticcondi- tionsandwashed severaltimeswithphosphate-bufferedsaline (PBS, pH 7.2). Viability was assessed as previously described (Elissondoetal.,2006).Viableandfree protoscoleces(2000per Leightonttube)wereculturedin10mlofmedium199,containing 60␮g/mlpenicillin,100␮g/mlstreptomycin, 50␮g/mlgentami- cinand4mg/mlglucose.Invitroincubationswereperformedat 37^◦C withoutchangesofmedium.5-FUandPTXwereaddedto themediumresultinginﬁnalconcentrationsof10,5and1␮g/ml.

Culturetubeswerefollowedmicroscopicallyeveryday.Samples ofprotoscoleces(approximately90–100protoscolecesin180␮lof incubationmedium)fromeachtreatmentandthecontrolswere takenevery5–6daysforviabilityassessment.Allexperimentswere performedintriplicateandwererepeatedthreetimes.Addition- ally,ultrastructuralstudieswithSEMandtransmissionelectron microscopy(TEM)wereperformed.

2.5. Ethicstatement

Animalproceduresandmanagementprotocolswerecarriedout in accordance withthe 2011revised formof The Guide for the CareandUseofLaboratoryAnimalspublishedbytheU.S.National Institute of Health. Unnecessary animal suffering was avoided throughoutthestudy.CF-1mice(bodyweight25±5g)wereused.

Theanimalswerehousedinatemperature-controlled(22±1^◦C), light-cycled(12-hlight/darkcycle)room.Foodand waterwere givenadlibitum.

2.6. Determinationofinfectivitytomice

Viableandfreeprotoscoleces(2000perLeightonttube)were culturedin10mlofmedium.5-FUwasaddedtothemediumat

(4)

Fig.1.SurvivalofE.granulosuslarvalcellsaftertreatmentwith5-FUandPTX.Eachpointrepresentsthemeanpercentageofvitalcellsfromthreedifferentexperiments (DMSO:dimethylsulphoxide).

aﬁnalconcentrationof10␮g/ml.Protoscolecesincubatedincul- turemediumcontainingDMSOservedascontrols.At24dayspost incubation (p.i.),protoscoleces ofeither 5-FUorcontrol groups wererinsedinmedium199.Aftersedimentation,theywereresus- pendedinmedium199supplemented with60␮g/ml penicillin, 100␮g/mlstreptomycinand50␮g/mlgentamicinandtheconcen- trationwasadjustedto3000protoscoleces/ml.Eachexperiment wasperformedinquadruplicate.

EightCF-1micewereallocatedintotwogroups(n=4):Thecon- troland5-FUgroups wereinfected byintraperitoneal injection with0.5mlofprotoscolecessuspensionfrominvitroDMSOand5- FUtreatments,respectively.At7monthspostinfection,micewere necropsiedandexaminedforlarvalgrowth.

2.7. Mouseinfectionandcollectionofcysts

FemaleCF-1micewereinfectedbyintraperitonealinoculation with1500E.granulosusprotoscoleces/animal,suspendedin0.5ml of medium199(Gibco). At8 monthspost-infection,mice with experimentalsecondaryCEwereeuthanized,andnecropsywas carried out immediatelythereafter. Atnecropsy, theperitoneal cavitywasopenedandthehydatidcystswerecarefullyremoved (Elissondoetal.,2009).

2.8. Proceduresforinvitroincubationofcysts

Groupsof10cysts(2–5mm)wereplacedinLeightontubescon- taining10mlofmedium199with5-FUorPTXatthefollowingﬁnal concentrationsof10,5and1␮g/ml.Culturesweremaintainedat 37^◦Cwithoutchangesofmediumduringtheentiredrugincubation period(Elissondoetal.,2007).Culturetubeswerefollowedmacro- andmicroscopicallyeveryday.Samplesofcystsfromeachofthe dosinggroupsandthecontrolsweretakenandthenﬁxedforelec- tronmicroscopy.Thecriteriaforcystsvitalitywasassessedonthe basisofstructuralvesicleintegrityandtheultrastructuralobserva- tionofthegerminallayerasdescribedbyElissondoetal.(2007).All

experimentswereperformedintriplicateandwererepeatedthree times.

2.9. Electronmicroscopy

E.granulosuscellsampleswereprocessedfor SEM(scanning electronmicroscopy)usingtheprotocoldescribedinAlbanietal.

(2010).Samplesofprotoscolecesandcystsculturedinvitrowere processedforSEMandTEMasdescribedbyElissondoetal.(2006, 2007).

2.10. Statisticalanalysis

Log-ranktestwasusedtoassessthesurvivaldifferencesoflarval cells andprotoscolecesafterexposureto5-FUandPTX.Allsta- tisticalanalyseswereperformedusingtheBioEstat5.0software (Ayresetal.,2007).Pvalueslessthan0.05wereconsideredtobe statisticallysigniﬁcant.

3. Results

3.1. InvitroE.granulosuscellculture

Theeffectof5-FUandPTXonthegrowthofE.granulosuscells isshowninFig.1.Controltreatmentalwaysshowedanincreasein cellnumberreachinganaverageof1.5×10⁶totalcellsatday7.

Incontrast,5-FUandPTXinhibitedthegrowthofE.granulosuscellsinatimedependentmanner.At5daysp.i.,thenumber oftreated-cellswas64%lowerthanthatobservedinuntreated- cells. Besides,5-FUand PTXat aconcentrationof 10␮g/mlnot onlyinhibitedthegrowthofcellsbutalsoprovokedaconsiderable reductioninthecellnumberafter7days.

StudiesbySEMrevealedthatstructuraldamagewasproduced indrug-treatedcells(Fig.2).At7daysp.i.,cellsincubatedwith 10␮g/mlof5-FUorPTXshowedmorphologicalalterationaslossof turgidity,cellularcontractionandpresenceofblebsonthesurface.

Fig.2. ScanningelectronmicroscopyofE.granulosusisolatedlarvalcellsincubatedinvitrowith5-FUandPTXduring7days.(a)Control(1400×);(b)detailofcontrolcells (10,000×);(c)cellstreatedwith10␮g/ml5-FU(10,000×);(d)cellstreatedwith10␮g/mlPTX(10,000×).

(5)

Fig.3.SurvivalofE.granulosusprotoscolecesafterexposureto5-FUandPTX.Eachpointrepresentsthemeanpercentageofvitalprotoscolecesfromthreedifferent experiments(DMSO:dimethylsulphoxide).

3.2. Invitroprotoscolecesincubation

ThesurvivalofE.granulosusprotoscolecesincubatedwithdif- ferentconcentrationsofof5-FUandPTXisshowninFig.3.Although bothtreatmentshadaprotoscolicidaleffect,5-FUhadaconsider- ablystrongereffectthandidPTX.

Control protoscoleces cultured in medium 199+DMSO remainedviable(94.7±0.2%)after30daysofincubation(Fig.3).No changesinstructureandultrastructurewereobservedthroughout theexperimentalperiod(Figs.4a,5a,5band6a).

Treatment with 5-FU produced dose- and time-dependent effects(Fig.3).Themaximumprotoscolicidaleffectwasfoundwith 10␮g/mlof5-FU.Viabilitywasreducedto28.3±8.4%after18days ofincubationandreached0%after24days.Lossofprotoscolecex viabilityin5␮g/mltreatedculturesbecameclearerafter18days, wherethepercentagevaluewas50.9±13.6%.Atday24,viability

was8.7±2.9%andreached0%after30days.Adelayedprotoscol- icidaleffectwasobservedwith1␮g/mlof5-FU.Inthiscase,the viabilitydiminishedtonear50%after24daysofincubation.Viabil- itywas0%atday48(datanotshown).

TheeffectofPTXwasalsodoseand time-dependent(Fig.3).

At30daysp.i.with10and5␮g/mlPTX,viabilityofprotoscoleces decreasedtoapproximately60%andreached0%after72days(data notshown).Treatmentwith1␮g/mlPTXalsoshowedprotoscolici- daleffect,with75.3%ofparasitesremainingviableincultureafter 30daysofincubation.Asitwasmentioned,5-FUhadastronger effectthandidPTX.Forthisreason,experimentsofinfectivityto miceweredevelopedonlywith5-FU.

Theresultsofviabilitytestcoincidewiththetegumentalalter- ationsobserveddailybyopticalmicroscope(Fig.4).Between2and 4daysp.i.,thepresenceofnumerousblebsinthetegumentofpro- toscolecestreatedwith10,5and1␮g/mlof5-FUwasobserved.

Fig.4.LightmicroscopyofE.granulosusprotoscolecesincubatedinvitrowith5-FUandPTX.(a)Controlprotoscoleces(cc,calcareuscorpuscles;h,hooks;4daysp.i.;300×);

(b)protoscolecesincubatedwith5␮g/ml5-FU(3daysp.i.;400×).Notethelossofhooks(arrow).Vesiculatedprotoscolex(arrowhead);(c)alteredprotoscolexafter3days ofincubationwith10␮g/ml5-FU.Notethepresenceofnumerousblebs(arrow)andthelostofhooks(300×),(d)vesiculatedprotoscolecesafter5dayswith10␮g/mlPTX (300×).

(6)

Otheralterationssuchasrostellardisorganizationandcontraction ofposteriorregioncouldbeseenafter3days(Fig.4bandc).After4 daysofincubationwithdifferentconcentrationsofPTX,vesiculated protoscoleceswereobserved(Fig.4d).Tegumentalalterationsin PTX-treatedprotoscolecescouldbeobservedlater,between5and 7daysp.i.

Theseresultswereconﬁrmedontheultrastructural levelby SEMandTEM(Figs.5and6).Controlculturesexhibitednoultra- structuralalterationsinparasitetissueduringthewholeincubation period(Figs.5aandband6a).Incontrast,morphologicalandultra- structuraldamagesweredetectedin treated protoscoleces.The primarysiteofdamagewasthetegumentoftheparasite.

Theultrastructuraleffectsobservedafter5-FUincubationwere greater than those caused by PTX (Figs. 5c–f and 6b and c).

At 12 days p.i., SEM analysis of protoscoleces incubated with 5-FU showed the presence of tegumental alterations, rostellar

disorganization,lossofhooks,andsheddingofmicrotrichesofthe scolexregion(Fig.5candd).Lossofmorphologywasevidentwith 5-FUatconcentrationof10␮g/ml(Fig.5e).PTXproducedrostellar disorganisationandlossofmicrotrichesoftherostellarregionafter 12days(Fig.5f).

At 12 days p.i.,observations by TEMof 5-FUtreated proto- scolecesrevealedtheinternaltissuealteredwiththepresenceof numerousvacuoles andlipiddroplets (Fig.6b).Upontreatment with PTX for 12 days, the internal tissue of protoscoleces was slightlyvacuolated(Fig.6c).

3.3. Determinationofinfectivitytomice

Controlprotoscolecesdevelopedanaverageof6±2.3gofcysts, similartotheinoculationoffreshly isolatedprotoscoleces. This resultshowedthattheinfectivityofcontrolprotoscoleceswasnot

Fig.5. ScanningelectronmicroscopyofE.granulosusprotoscolecesincubatedinvitrowith5-FUandPTX.(a)Invaginatedcontrolprotoscolex(18daysp.i.;600×);(b) evaginatedcontrolprotoscolex(rr,rostelarregion;s,suckers;sr,somaregion;18daysp.i.;600×);(c)alteredevaginatedprotoscolexincubatedwith1␮g/ml5-FUduring12 days.Thesheddingofmicrotrichescanbeobservedinthescolexregion(700×);(d)Lossofhooksandmicrotrichesandpresenceofnumerousblebs(arrow)(5␮g/ml5-FU;

12daysp.i.;600×);(e)completelossofmorphology.Notethepresenceofnumerousblebs(arrow)(10␮g/ml5-FU;12daysp.i.;850×);(f)alteredprotoscolexafter18days with10␮g/mlPTX(500×).

(7)

Fig.6.TEMofE.granulosusprotoscolecesincubatedinvitrowith5-FUandPTX.(a) Somaregionofacontrolprotoscolex(12daysp.i.;g,glycocalix;dc,distalcytoplasm;

12,000×);(b)Treatedprotoscolex(12daysp.i.,10␮g/ml5-FU).Internaltissuewas alteredwiththepresenceofvacuoles(arrows)andlipiddroplets(l)(12,000×);(c) protoscolexincubatedwith10␮g/mlPTX(12daysp.i.).Notethevacuolationofde distalcitoplasmandinternaltissue(arrows)(15,000×).

affectedduringinvitroincubationfor24days.Lossofinfectivity inprotoscolecesincubatedwith5-FUafter24dayswasobserved, sincealloftheprotoscolecesfailedtodevelopintocystsfollowing theirinoculationintomice.

3.4. Invitrocystsincubation

Survivalof cystsincubatedwiththedifferentconcentrations of5-FUandPTXareshowninFig.7.Theeffectwasmorerapidly detectedincyststreatedwith5-FUthanwhenPTXwereused.

AscanbeseeninFig.8,incubationofE.granulosuscystsinthe presenceof5-FUandPTXresultedindramaticalterationswithin 3to5daysafterinitiationoftreatment.Atlowerconcentrations, similarmorphologicalchangesoccurred,althoughatalowerrate (datanotshown).Alreadyvisiblemacroscopically,theparasitetis- suedetachedfromtheinteriorliningofthelaminatedlayerand formedadenselypackedaggregateinsidethevesicles.Thelami- natedlayerbecametranslucent,mostlybecauselargepartsofthe parasitetissuehadbeenredistributedtoanothersite.

InspectionofcontrolcystsbySEMandTEMrevealedthatthey exhibitedtypicalfeaturesofE.granulosusmetacestodes,withadis- tinctacellularouterlaminatedlayerandanintactgerminallayer comprisedofamultitudeofdifferent,morphologicallyintactcell types(Fig.9aandb).

Theultrastructuraleffectobservedafter5-FU-incubationwas greaterthanthatcausedbyPTX.Clearly,after3dayswith5-FU (10␮g/ml)thegerminallayerlostthemulticellularstructurefea- ture(Fig.9c).At10 daysp.i.,studiesbyTEMrevealedcomplete destructionoftheparasitetissue withthepresence oflamellar bodies(Fig.9d).Ontheotherhand,lesscellswereobservedinthe germinallayerofcystsincubatedwith10␮g/mlofPTX(Fig.9e).

After10 days,thepresenceofnumerous vacuoleswasdetected (Fig.9f).

4. Discussion

Many similarities exist between cancer cells and parasites.

Therefore,a promising startingpoint forthediscoveryof novel drugs to combat parasites is to examine available compounds developedagainstcancerforantiparasiticproperties(Klinkert&

Heussler,2006).Severaldrugs inhibiting proliferationof cancer cellshave beenassayedonEchinococcus metacestodesandpro- toscoleces. This work describes for the ﬁrst time the in vitro anthelminticeffectoftheanti-cancerdrugs5-FUandPTXonE.

granulosuslarvalcells,protoscolecesandcyst.

Thereare numerous routes and schedules of administration available for 5-FU. The weekly bolus administration of 5-FU at 15mg/kg in clinic produces initial peak plasma levels of approximately50to100␮g/mlwhichrapidlydeclinebyseveral ordersofmagnitude(Calabro-Jonesetal.,1982).Arecommended starting doseof single-agent5-FUgiven by protractedinfusion is 300mg/m²/day (Harris et al., 1990). Continuous infusion of 2300mg/m²/dayproduces5-FUserumconcentrationsontheorder of1␮g/ml(Gremetal.,1993).Inaddition,theexposureto1.3␮g/ml 5-FUdoesnotproducecytotoxiceffectonprimaryendometrialcell cultures(epithelialandstromalcells)(Ngôetal.,2010).

AtthemaximumtoleratedandrecommendedPhaseIIdosesfor PTXadministeredasa6-hinfusion,plasmalevelshaveapproached 10␮Mfor2–4h,andhaveexceeded1␮Mfor24h,and0.1␮Mfor 48h(Rowinskyetal.,1988).Besides,PTXdidnotalterthegrowth ofﬁbroblastsataconcentrationof8.54␮g/ml(Estesetal.,1998).

Ontheotherhand,cleareffectsonPlasmodiumfalciparumwere demonstratedusing5-FUat1.6␮g/mlconcentration(Rathodetal., 1989).Theactivityagainstapicomplexanparasiteswasdetermined usingPTXatconcentrationsbetween0.25to10␮g/ml(Estesetal.,

(8)

Fig.7.SurvivalofE.granulosuscystsaftertreatmentwith5-FUandPTX.Viabilitywasmeasuredonthebasisofvesicleintegrity(DMSO:dimethylsulphoxide).

1998).Itwasthereforedecidedtotest5-FUandPTXatconcentra- tions1,5and10␮g/ml.

Nodifferencesbetweentheeffectof5-FUandPTXontheviabil- ityofgerminalcellswerefound.5-FUorPTXinhibitedthegrowth ofE.granulosuscellsinatimedependentmanner.Moreover,5-FU orPTXataconcentrationof10␮g/mlnotonlyinhibitedthegrowth ofcellsbutalsoprovokedaconsiderablereductioninthecellnum- ber.Cellsexposedto5-FUorPTXshowedmorphologicalalteration aslossofturgidity,cellularcontractionandpresenceofblebson cellsurface.

Interesting,larvalcellsweremoresensitivetothedrugsthan protoscolecesandcysts.Isolatedcellsofgerminallayeraremore exposedtotheactionofthedrugsduetotheyaredetachedfrom theirnormalenvironmentandcouldthusbemoresensitive.Pro- toscolecesandcystsare multicellularorganismssurroundedby tegumentthatactsasbarrieragainstthedrugs(Galindoetal.,2008;

Urrea-Parisetal.,1999).Anotherpossibleexplanationcouldbethat asdrugsprimarilytargetcellsinmitosis,post-mitoticcellsofentire larvaecouldsurvivelonger.

Theefﬁcacyof 5-FUandPTX wasalsodemonstratedinvitro onE.granulosusprotoscoleces,andmarkedly differencesonthe effectivenessofbothdrugsweredetected.5-FUhadaconsiderably strongerprotoscolicidaleffectthandidPTX.Besides,itseffectwas dose-andtime-dependent,provokingthecompletelossofviabil- ityafter24daysofincubation.Incontrast,thelossofviabilitywas slowerinPTXtreatedprotoscoleces,reachingtoapproximately60%

after30days.

Moreover,5-FUwasabletokillE.granulosusprotoscoleces,since followinginoculationoftreatedparasitesinmicenocystscouldbe recoveredafter4monthspostinfectioninallmiceinfectedwith 5-FU-treatedparasites.

Themorphologicalandultrastructuralalterationsincludedcon- tractionofthesomaregion,formationofblebsonthetegument, rostellardisorganization,lossofhooks,sheddingofmicrotriches, andthepresenceofvacuolesandlipiddroplets.Thesamealter- ationshavealsobeenreportedbyotherauthorsworkingwithother

drugslikebenzimidazoles(Pérez-Serranoetal.,1994;Elissondo et al., 2006), praziquantel(Urrea-Paris et al.,2000), ivermectin (Casado et al., 2002; Elissondo et al., 2009), and nitasoxanide (Walkeretal.,2004).

Likewise,5-FUproducedagreatereffectonE:granulosusmurine cystthanthatobservedwithPTX.Acorrelationbetweentheinten- sityofdamageandtheconcentrationofthedrugwasfound.The ultrastructural changesobservedbySEM andTEMincludedthe lossofthecharacteristicmulticellularappearanceofthegermi- nalmembrane.Furthermore,thesameultrastucturalalterationsin cellculturesaftertreatmentwith5-FUandPTXcouldbeobserved.

These changes have been also observed in E. granulosus cysts followinginvitrotreatmentwithothersanticancerdrugssuchas2- methoxyestradiol,genesteinandotherisoﬂavones(Naguleswaran etal.,2006;Spicheretal.,2008a).Theseultrastructuralchanges weresimilartothosereportedbyothersauthors(Elissondoetal., 2007;Walkeretal.,2004).

Thedifferentmechanismofactioncouldexplainthedisparate efficacyofthesedrugsagainstE.granulosus.5-FUisananalogue of uracil with a fluorine atom at the C-5 position instead of hydrogen.Itrapidlyentersthecellusingthesamefacilitatedtrans- portmechanismasuracil.Thedrugisconvertedintracellularlyto severalactive metabolites:fluoro-deoxyuridinemonophosphate (FdUMP),fluorodeoxyuridinetriphosphate(FdUTP),andfluorouri- dinetriphosphate(FUTP).Theactivemetabolitesof5-FUdisrupt RNAsynthesis(FUTP),inhibittheactionofthymidylatesynthase (TS)–anucleotidesyntheticenzyme(FdUMP)–andcanalsobe directlymisincorporatedintoDNA(FdUTP)(Longleyetal.,2003).

E.granulosusgenomeencodesaTS(EgrG000260100)(Zhengetal., 2013)withconsiderablehomologywithdehumanenzyme.

Bytheotherhand,PTXpromotestheassemblyofmicrotubules andstabilizestubulinpolymersbypreventingtheirdepolymeriza- tion.Thisunusualstabilityresultsintheinhibitionofthenormal dynamicreorganizationofthemicrotubulenetwork(Blagosklonny and Fojo, 1999). Since microtubules are important for mitosis andinterphasefunctionssuchasmaintenanceofcellshape,cell

Fig.8.Morphologicaleffectsof5-FUandPTXtreatmentsonE.granulosuscysts.(a)Controlcyst(3daysp.i.);(b)cystincubatedwith10␮g/mlof5-FU(arrow,germinallayer;

3daysp.i.);(c)cystincubatedwith10␮g/mlofPTX(arrow,germinallayer;5daysp.i.).Bar=300␮m.

(9)

Fig.9.RepresentativeimagesofSEMandTEMofmurinecystsincubatedinvitrowith5-FUandPTX.((a)and(b))Controlcysts(a)controlcystwithanintactgerminallayer (gl,germinallayer;ll,laminarlayer;3daysp.i.;SEM500×);(b)Controlcyst(ll,laminarlayer;mt,microtriches;dc,distalcitoplasm;10daysp.i.;TEM12,000×);((c)and(d)) cystincubatedwith10␮g/ml5-FU.(c)Notetheextensivedamageofthegerminallayer(3daysp.i.;SEM300×)(d)Theinternaltissuewasseverelyaffected((b)residual lamillarbodies;10daysp.i.;TEM15,000×);((d)and(e))cystsincubatedwith10␮g/mlPTX.(d)Thegerminallayerisaltered(3daysp.i.;SEM250×);(e)notethepresence ofvacuoles(arrows)(10daysp.i.;TEM12,000×).

motility,and intracellular transport, PTX might beexpected to affectcells duringbothinterphaseandmitoticcellcyclephases (Rowinskyetal.,1988).

In thesearch foran effectivedrug againstE. granulosus, we showedthat5-FUandPTX,atclinicallyachievableconcentrations, inhibitedthesurvivaloflarvalcells,protoscolecesandmetacestodes.Invivostudiestotesttheantiparasiticactivitiesof5-FUand PTXarecurrentlybeingundertakenonthemurinemodelofcystic echinococcosis.

Acknowledgements

Thisworkwassupportedby thePICT12 no.1164(ANPCyT, Argentina), PIP 0029 (CONICET, Argentina) and Universidad Nacional de Mar del Plata (Grant EXA 581/12 and Grant EXA 672/14),Argentina.

References

Albani, C.M., Elissondo, M.C., Cumino, A.C., Chisari, A., Denegri, G.M., 2010.

PrimarycellcultureofEchinococcusgranulosusdevelopedfromthecysticger- minallayer: biologicalandfunctionalcharacterization.Int.J.Parasitol.40, 1269–1275.

Ayres,M.,AyresJr.,M.,Ayres,D.L.,Santos,A.S.,2007.BioEstat5.0aplicaçõesestatís- ticasnasáreasdasciênciasbiomédicas,fifthed.ImprensaOficialdoEstadodo Pará,Brazil.

Blagosklonny,M.V.,Fojo,T.,1999.Moleculareffectsofpaclitaxel:mythsandreality (acriticalreview).Int.J.Cancer83,151–156.

Brunetti,E.,Garcia,H.H.,Junghanss,T.,2011.Cysticechinococcosis:chronic,complex,andstillneglected.PLoSNegl.Trop.Dis.5(7),e1146.

Budke,C.M.,Carabin,H.,Ndimubanzi,P.C.,Nguyen,H.,Rainwater,E.,Dickey,M., Bhattarai,R.,Zeziulin,O.,Qian,M.B.,2013.ASystematicreviewofthelitera- tureoncysticechinococcosisfrequencyworldwideanditsassociatedclinical manifestations.Am.J.Trop.Med.Hyg.88,1011–1027.

Bygott,J.M.,Chiodini,P.L.,2009.Praziquantel:Neglecteddrug?Ineffectivetreat- ment? Or therapeutic choice in cystic hydatid disease? Acta Trop. 111, 95–101.

(10)

Calabro-Jones,P.M.,Byﬁeld,J.E.,Ward,J.F.,Sharp,T.R.,1982.Time–doserelation- shipsfor5-ﬂuorouracilcytotoxicityagainsthumanepithelialcancercellsin vitro.CancerRes.42,4413–4420.

Casado,N.,Moreno,M.,Urrea-París,M.,Rodríguez-Caabeiro,F.,2002.Couldiver- mectinhaveasynergiceffectwithalbendazoleinhydatidosistherapy?Invitro studies.Parasitol.Res.88,153–159.

Ceballos,L.,Elissondo,M.C.,Moreno,L.,Dopchiz,M.,SánchezBruni,S.,Denegri,G., Alvarez,L.,Lanusse,C.,2008.Albendazoletreatmentincysticechinococcosis:

pharmacokineticsandclinicalefﬁcacyoftwodifferentaqueousformulations.

Parasitol.Res.103,355–362.

Elissondo,M.C.,Ceballos,L.,Alvarez,L.,SánchezBruni,S.,Lanusse,C.,Denegri,G., 2009.Flubendazoleandivermectininvitrocombinationtherapyproducesa markedeffectonEchinococcusgranulosusprotoscolecesandmetacestodes.Para- sitol.Res.105,835–842.

Elissondo,M.C.,Ceballos,L.,Dopchiz,M.,Andresiuk,V.,Alvarez,L.,SánchezBruni, S.,Lanusse,C.,Denegri,G.,2007.Invitroandinvivoeffectsofﬂubendazoleon Echinococcusgranulosusmetacestodes.Parasitol.Res.100,1003–1009.

Elissondo,M.C.,Dopchiz,M.,Ceballos,L.,Alvarez,L.,SánchezBruni,S.,Lanusse,C., Denegri,G.,2006.InvitroeffectsofﬂubendazoleonEchinococcusgranulosus protoscoleces.Parasitol.Res.98,317–323.

Estes,R.,Vogel,N.,Mack,D.,McLeod,R.,1998.Paclitaxelarrestsgrowthofintracel- lularToxoplasmagondii.Antimicrob.AgentsChemother.42,2036–2040.

Galindo,M.,Schadebrodt,G.,Galanti,N.,2008.Echinococcusgranulosus:cellularter- ritoriesandmorphologicalregionsinmatureprotoscoleces.Exp.Parasitol.199, 524–533.

Grem,J.L.,McAtee,N.,Steinberg,S.M.,Hamilton,J.M.,Murphy,R.F.,Drake,J.,Chisena, T.,Balis,F.,Cysyk,R.,Aibuck,S.G.,Sorensen,J.M.,Chen,A.P.,Goldstein,L.,Jordan, E.,Setser,A.,Goldspiel,B.,DeCarvalho,M.,Allegra,C.J.,1993.APhaseIstudyof continuousinfusion5-ﬂuorouracilpluscalciumleucovorinincombinationwith N-(phosphonacetyl)-l-aspartateinmetastaticgastrointestinaladenocarcinoma.

CancerRes.53,4828–4836.

Harris,B.E.,Song,R.,Soong,S.J.,Diasio,R.B.,1990.Relationshipbetweendihydropy- rimidinedehydrogenaseactivityandplasma5-ﬂuorouracillevelswithevidence forcircadianvariationofenzymeactivityandplasmadruglevelsincancer patientsreceiving5-ﬂuorouracilbyprotractedcontinuousinfusion.CancerRes.

50,197–201.

Heidelberger,C.,Chaudhuari,N.K.,Daneberg,P.,Mooreh,D.,Griesbach,L.,Duschin- sky,K.,Schnitzer,R.J.,Pleven,E:,1957.Fluorinatedpyrimidines.Anewclassof tumorinhibitorycompounds.Nature179,663–666.

Hemer,S.,Brehm,K.,2012.Invitroefﬁcacyoftheanticancerdrugimatinibon Echinococcusmultilocularislarvae.Int.J.Antimicrob.Agents40,458–462.

Hemphill,A.,Müller,J.,2009.Alveolarandcysticechinococcosis:towardsnovel chemotherapeuticaltreatmentoptions.J.Helminthol.83,99–111.

Hemphill,A.,Spicher,M.,Stadelmann,B.,Mueller,J.,Naguleswaran,A.,Gottstein,B., Walker,M.,2007.Innovativechemotherapeuticaltreatmentoptionsforalveolar andcysticechinococcosis.Parasitology134,1657–1670.

Huizing,M.T.,SewberathMisser,V.H.,Pieters,R.C.,tenBokkelHuinink,W.W.,Veen- hof,C.H.N.,Vermorken,J.B.,Pinedo,H.M.,Beijnen,J.H.,1995.Taxanes:anew classofantitumoragents.CancerInvest.13,381–404.

Hübner,C.,Wiehr,S.,Kocherscheidt,L.,Wehrl,H.,Pichler,B.J.,Schmid,A.,Kern, P.,Soboslay,P.T.,2010.EffectsofinvitroexposureofEchinococcusmultilocu- larismetacestodestocytostaticdrugsoninvivogrowthandproliferationofthe parasite.Parasitol.Res.107,459–463.

Klinkert,M.Q.,Heussler, V.,2006.Theuseofanticancerdrugsinantiparasitic chemotherapy.MiniRev.Med.Chem.6,131–143.

Küster,T.,Lense,N.,Barna,F.,Hemphill,A.,Kindermann, M.K.,Heinicke, J.W., Vock,C.A.,2012. Anewpromising applicationfor highlycytotoxic metal compounds:␩6-areneruthenium(II)phosphitecomplexesforthetreatmentof alveolarechinococcosis.J.Med.Chem.55,4178–4188.

Liance,M.,Nemati,F.,Bories,C.,Couvreur,P.,1993.Experiencewithdoxorubicin- boundpolyisohexylcyanoacrylatenanoparticlesonmurinealveolarechinococ- cosisoftheliver.Int.J.Parasitol.23,427–429.

Longley,D.B.,Harkin,D.P.,Johnston,P.G.,2003.5-Fluorouracil:mechanismsofaction andclinicalstrategies.Nat.Rev.Cancer3,330–338.

McManus,D.P.,Gray,D.J.,Zhang,W.,Yang,Y.,2012.Diagnosis,treatment,andman- agementofechinococcosis.Br.J.Med.Med.Res.344,39–44.

Moro, P., Schantz,P.M., 2009. Echinococcosis: areview. Int. J. Infec.Dis. 13, 125–133.

Naguleswaran,A.,Spicher,M.,Vonlaufen,N.,Ortega-Mora,L.M., Torgerson,P., Gottstein,B.,Hemphill,A.,2006.Invitrometacestodicidalactivitiesofgenis- teinandotherisoﬂavonesagainstEchinococcusmultilocularisandEchinococcus granulosus.Antimicrob.AgentsChemother.50,3770–3778.

Ngô,C.,Nicco,C.,Leconte,M.,Chéreau,C.,Weill,B.,Batteux,F.,Chapron,C.,2010.

Antiproliferativeeffectsofanastrozole,methotrexate,and5-ﬂuorouracilon endometriosisinvitroandinvivo.Fertil.Steril.94,1632–1638.

Pawlowski,Z.S.,Eckert,J.,Vuitton,D.A.,Ammann,R.W.,Kern,P.,Craig,P.S.,Dar, K.F.,DeRosa,F.,Filice,C.,Gottstein,B.,Grimm,F.,Macpherson,C.N.L.,Sato,N., Todorov,T.,Uchino,J.,vonSinner,W.,Wen,H.,2001.Echinococcosisinhumans:

clinicalaspects,diagnosisandtreatment.In:Eckert,J.,Gemmell,M.A.,Meslin, F.X.,Pawlowski,Z.S.(Eds.),WHO/OIEManualonEchinococcosisinHumansand Animals:APublicHealthProblemofGlobalConcern.WorldOrganisationfor AnimalHealth,Paris,France,pp.20–66.

Pérez-Serrano,J.,Casado,N.,Denegri,G.,Rodríguez-Caabeiro,F.,1994.Theeffectsof albendazoleandalbendazolesulphoxidecombination-therapyonEchinococcus granulosusinvitro.Int.J.Parasitol.24,219–224.

Pouvelle,B.,Farley,P.J.,Long,C.A.,Taraschi,T.F.,1994.Taxolarreststhedevelopment ofblood-stagePlasmodiumfalciparuminvitroandPlasmodiumchabaudiadami inmalaria-infectedmice.J.Clin.Invest.94,413–417.

Rathod,P.K.,Khatri,A.,Hubbert,T.,Milhous,W.K.,1989.Selectiveactivityof5- ﬂuorooroticacidagainstPlasmodiumfalciparuminvitro.Antimicrob.Agents Chemother.33,1090–1094.

Rowinsky,E.K.,Donerhower,R.C.,1995.Paclitaxel(taxol).N.Engl.J.Med.332, 1004–1014.

Rowinsky,E.K.,Donehower,R.C.,Jones,R.J.,Tucker,R.W.,1988.Microtubulechanges andcytotoxicity inleukemiccelllinestreatedwithtaxol. CancerRes. 48, 4093–4100.

Rutman,R.J.,Cantarow,A.,Paschkis,K.E.,1954.Studieson2-acetylaminoﬂuorene carcinogenesis:III.Theutilizationofuracil-2-C14bypre-neoplasticratliver.

CancerRes.14,119–123.

Spicher,M.,Naguleswaran,A.,Ortega-Mora,L.M.,Müller,J.,Gottstein,B.,Hemphill, A.,2008a.Invitroandinvivoeffectsof2-methoxyestradiol,eitheraloneor combinedwithalbendazole,againstEchinococcusmetacestodes.Exp.Parasitol.

119,475–482.

Spicher,M.,Roethlisberger,C.,Lany,C.,Stadelmann,B.,Keiser,J.,Ortega-Mora,L.M., Gottstein,B.,Hemphill,A.,2008b.InvitroandinvivotreatmentsofEchinococcus protoscolecesandmetacestodeswithartemisininandartemisininderivatives.

Antimicrob.AgentsChemother.52,3447–3450.

Stamatakos,M.,Sargedi,C.,Stefanaki,C.,Saﬁoleas,C.,Matthaiopoulou,I.,Saﬁoleas, M.,2009.Anthelminthictreatment:anadjuvanttherapeuticstrategyagainst Echinococcusgranulosus.Parasitol.Int.58,115–120.

Stojkovic,M.,Zwahlen,M.,Teggi,A.,Vutova,K.,Cretu,C.M.,Virdone,R.,Nicolaidou, P.,Cobanoglu,N.,Junghanss,T.,2009.Treatmentresponseofcysticechinococ- cosistobenzimidazoles:asystematicreview.PLoSNegl.Trop.Dis.3,e524, http://dx.doi.org/10.1371/journal.pntd.0000524.

Urrea-Paris,M.,Moreno,M.,Casado,N.,Rodriguez-Caabeiro,F.,1999.Echinococcus granulosus:praziquanteltreatmentagainstthemetacestodestage.Parasitol.Res.

85,999–1006.

Urrea-Paris,M.,Moreno,M.,Casado,N.,Rodríguez-Caabeiro,F.,2000.Invitroeffect ofpraziquanteandalbendazolecombinationtherapyofthelarvalstageof Echinococcusgranulosus.Parasitol.Res.86,957–964.

Walker,M.,Rossignol,J.,Torgerson,P.,Hemphill,A.,2004.Invitroeffectsofnitazox- anideonEchinococcusgranulosusprotoscolecesandmetacestodes.J.Antimicrob.

Chemother.54,609–616.

Wani,M.,Taylor,H.L.,Wall,M.E.,1971.PlantantitumoragentsVI.Theisolation andstructureofTaxol,anovelantileukemicandantitumoragentfromTaxus brevifolia.J.Am.Chem.Soc.93,2325–2327.

Zheng,H.,Zhang,W.,Zhang,L.,Zhang,Z.,Li,J.,Lu,G.,Zhu,Y.,Wang,Y.,Huang,Y.,Liu, J.,Kang,H.,Chen,J.,Wang,L.,Chen,A.,Yu,S.,Gao,Z.,Jin,L.,Gu,W.,Wang,Z.,Zhao, Li.,Shi,B.,Wen,H.,Lin,R.,Jones,K.,Brejova,M.,Vinar,B.,Zhao,T.,McManus,G., Zhou,Z.D.,Wang,Y.S.,2013.ThegenomeofthehydatidtapewormEchinococcus granulosus.Nat.Genet.45,1168–1175.